Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-434-1 | CAS number: 471-01-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
There was some evidence of carcinogenicity of isophorone in male rats (kidney tumors, preputial gland carcinomas). The kidney tumors can be attributed to an α2u-globulin associated mechanism. The observed nephropathy in male rats is therefore irrelevant to other species. As the preputium is only investigated histopathologically when gross lesions are found, neither true tumor incidences from this study nor from historical controls are available. Therefore, the higher incidence of preputial gland tumors in high dose male rats cannot be put into perspective. There was equivocal evidence of carcinogenicity for male mice (liver tumors, mesenchymal tumors of the integumentary system). There was no evidence of carcinogenicity of isophorone in female rats and mice.
Key value for chemical safety assessment
Justification for classification or non-classification
Based on the results of the carcinogenicity tests, isophorone should be classified with Carc cat 3, R40 according to Directive 67/548/EEC and Carc 2, H351 according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Additional information
In an NTP 2-year study (NTP, 1986) Fischer-344 rats (50 animals/dose/sex) were exposed by gavage to daily doses (5 days/week) of 0, 250, or 500 mg/kg isophorone in corn oil. The overall survival rate was low (males 33/50, 33/50, 14/50; females 30/50, 23/50, 20/50). Increased mortality was observed after week 98 in males in the 500 mg/kg bw dose group. Compound related clinical signs were not observed. Throughout the study, the mean body weights of high dose males averaged 5 % lower than vehicle controls. During the second year, the mean body weights of high dose females averaged 8 % lower than vehicle controls.
Dosed males showed proliferative lesions of the kidney (tubular cell hyperplasia: 0/50, 1/50, 4/50; tubular cell adenoma: 0/50, 0/50, 2/50; tubular cell adenocarcinoma: 0/50, 3/50, 1/50; epithelial hyperplasia of the renal pelvis: 0/50, 5/50, 5/50) and an increased mineralization of the medullary collecting ducts (1/50, 31/50, 20/50). Low dose males revealed more severe nephropathy than is commonly observed in aging F344 rats. Female rats only showed a statistically significant increase in nephropathy (21/50, 39/50, 32/50) with no further findings in the kidneys.
Carcinomas of the preputial gland were increased in high dose males only (0/50, 0/50, 5/50). The preputium is only investigated histopathologically when gross lesions are found, therefore neither true tumor incidences from this study nor from historical controls are available. As also two clitoral gland tumors were found in low dose females, a treatment related effect cannot be discounted.
Investigations on α2u-globulin induced nephropathy:
Various chemicals are known to induce nephropathy in male rats only. Only 60 % of α2u-globulin is reabsorbed in the kidney of male rats. 40 % of this low molecular weight protein remains in the filtrate and is excreted to the urine. The amount of α2u-globulin in female rats is 120 times lower and the protein is nearly absent in mice and in men. Chemicals that induce α2u-globulin nephropathy bind to the protein in the liver of the animals; these conjugates are difficult to hydrolyse and induce the formation of hyaline droplets which accumulate in the tubules (Charbonneau and Swenberg, 1988; Swenberg et al., 1989).
Isophorone as well as the proposed metabolites isophorol and dihydroisophorone form protein complexes with α2u-globulin in vivo, (SDS-page and immunoblotting after 14 d isophorone administration; GC/MS determination of isolated protein complexes) (Saito et al., 1992; Strasser et al., 1988). The degradation of α2u-globulin via lysosomal proteinases was decreased by 33 % (Lehman-McKeeman et al., 1990). In a further experiment with male NCI-Black-Reiter rats (strain is unable to synthesize the hepatic form of the low molecular weight protein α2u -globulin) isophorone administration, which clearly induced kidney lesions in male F344 rats, failed to induce nephropathy, α2u-globulin or the formation of hyaline droplets (Dietrich and Swenberg, 1991). It is thus concluded that the observed nephropathy in male rats is caused via the α2u-globulin mechanism and therefore irrelevant to other species.
In a parallel NTP 2-year gavage study with B6C3F1 mice (50 animals/dose/sex) animals were dosed daily (5 days/week) with 0, 250, or 500 mg/kg isophorone in corn oil. The survival of male mice was low (13/50, 13/50, 18/50) in contrast to female mice, where there was a trend towards increased survival of dosed animals relative to the controls (24/50, 33/50, 34/50). In high dose males, there was an increased incidence of hepatocellular adenomas and carcinomas (18/48, 18/50, 29/50). Increased incidences of coagulative liver necrosis (3/48, 10/50, 11/50) and hepatocytomegaly (23/48, 39/50, 37/50) were found in low and high dose males.
Mesenchymal tumors of the integumentary system (6/48, 8/50, 14/50) were increased in high dose males. An increased incidence of lymphomas or leukemias was noted in low dose males only (8/48, 18/50, 5/50). These results were interpreted as chemically related marginal increases in number of neoplasms (equivocal evidence).
Compound related non-neoplastic or neoplastic lesions associated with isophorone exposure were not seen in female mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.